These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 9021192)

  • 1. Effects of benzoxazinorifamycin KRM-1648 on cytokine production at sites of Mycobacterium avium complex infection induced in mice.
    Tomioka H; Sato K; Shimizu T; Sano C; Akaki T; Saito H; Fujii K; Hidaka T
    Antimicrob Agents Chemother; 1997 Feb; 41(2):357-62. PubMed ID: 9021192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the Chinese traditional medicine mao-bushi-saishin-to on therapeutic efficacy of a new benzoxazinorifamycin, KRM-1648, against Mycobacterium avium infection in mice.
    Shimizu T; Tomioka H; Sato K; Sano C; Akaki T; Dekio S; Yamada Y; Kamei T; Shibata H; Higashi N
    Antimicrob Agents Chemother; 1999 Mar; 43(3):514-9. PubMed ID: 10049260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mechanism of bacterial regrowth at the sites of infection in Mycobacterium avium complex-infected mice during treatment with chemotherapeutic agents].
    Sato K; Tomioka H; Maw WW; Saito H
    Kekkaku; 1995 Dec; 70(12):673-8. PubMed ID: 8551714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Profiles of expression of the therapeutic efficacy of KRM-1648 in mice infected with Mycobacterium avium complex at different challenge doses].
    Shimizu T; Ogasawara K; Sato K; Sano C; Tomioka H
    Kekkaku; 2001 May; 76(5):413-8. PubMed ID: 11449696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of secretory leukocyte protease inhibitor on the production of some cytokines and nitric oxide by murine peritoneal macrophages in response to lipopolysaccharide stimulation and M. avium complex infection].
    Sano C; Shimizu T; Sato K; Ogasawara K; Tomioka H
    Kekkaku; 1999 Jul; 74(7):563-70. PubMed ID: 10481411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Yokuinin on the therapeutic efficacy of a new benzoxazinorifamycin KRM-1648 against Mycobacterium avium infection.
    Shimizu T; Tomioka H; Sato K; Sano C; Yamada Y; Shibata H; Higashi N
    Int J Antimicrob Agents; 1999 Jan; 11(1):69-74. PubMed ID: 10075281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapeutic efficacy of a newly synthesized benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex infection induced in mice.
    Tomioka H; Saito H; Sato K; Yamane T; Yamashita K; Hosoe K; Fujii K; Hidaka T
    Antimicrob Agents Chemother; 1992 Feb; 36(2):387-93. PubMed ID: 1605603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of tumour necrosis factor-alpha in combination with interferon-gamma or interleukin-1 in the induction of immunosuppressive macrophages because of Mycobacterium avium complex infection.
    Tomioka H; Maw WW; Sato K; Saito H
    Immunology; 1996 May; 88(1):61-7. PubMed ID: 8707352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic effects of benzoxazinorifamycin KRM-1648 administered alone or in combination with glycyrrhizin against Mycobacterium avium complex infection in mice].
    Shimizu T; Tomioka H; Sato K; Akaki T; Ogasawara K; Kawahara S
    Kekkaku; 1999 Aug; 74(8):617-21. PubMed ID: 10487030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of various steroidal and non-steroidal anti-inflammatory drugs on in-vitro IL-10 production of murine peritoneal macrophages infected with Mycobacterium avium complex].
    Shimizu T; Sano C; Sato K; Tomioka H
    Kansenshogaku Zasshi; 1997 Sep; 71(9):910-7. PubMed ID: 9339628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The modulating effects of proinflammatory cytokines interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha), and immunoregulating cytokines IL-10 and transforming growth factor-beta (TGF-beta), on anti-microbial activity of murine peritoneal macrophages against Mycobacterium avium-intracellulare complex.
    Sano C; Sato K; Shimizu T; Kajitani H; Kawauchi H; Tomioka H
    Clin Exp Immunol; 1999 Mar; 115(3):435-42. PubMed ID: 10193415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro antimicrobial activities of quinolones, rifamycins and macrolides against Mycobacterium tuberculosis and M.avium complex: attempt to establish new assay methods which accurately reflect therapeutic effects of test agents in vivo].
    Sato K; Tomioka H
    Kekkaku; 1999 Jan; 74(1):63-70. PubMed ID: 10067057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of half-sized secretory leukocyte protease inhibitor and Chinese traditional medicines, yokuinin and mao-bushi-saishin-to, on therapeutic efficacies of benzoxazinorifamycin KRM-1648 against Mycobacterium avium complex infection induced in mice].
    Sato K; Shimizu T; Tomioka H; Kawahara S
    Kekkaku; 1998 Aug; 73(8):501-6. PubMed ID: 9780605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of in vivo therapeutic efficacy of a new benzoxazinorifamycin, KRM-1648, in SCID mouse model for disseminated Mycobacterium avium complex infection.
    Emori M; Tomioka H; Sato K; Saito H
    Int J Antimicrob Agents; 1998 Apr; 10(1):59-65. PubMed ID: 9624545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial activities of benzoxazinorifamycin (KRM-1648) and clarithromycin against Mycobacterium avium-intracellulare complex within murine peritoneal macrophages, human macrophage-like cells and human alveolar epithelial cells.
    Sato K; Tomioka H
    J Antimicrob Chemother; 1999 Mar; 43(3):351-7. PubMed ID: 10223590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of the Chinese traditional medicines "mao-bushi-saishin-to" and "yokuinin" on the antimycobacterial activity of murine macrophages against Mycobacterium avium complex infection].
    Shimizu T; Sano C; Akaki T; Ogasawara K; Sato K; Tomioka H
    Kekkaku; 1999 Sep; 74(9):661-6. PubMed ID: 10535279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The expression of ICAM-1 on macrophages stimulated with Mycobacterium avium complex and its control by some regulatory cytokines].
    Maw WW; Tomioka H; Sato K; Saito H
    Kekkaku; 1996 Oct; 71(10):561-7. PubMed ID: 8936990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [MICs and MBCs of levofloxacin, clarithromycin, and KRM-1648 for Mycobacterium tuberculosis and M. avium complex residing in MONO-MAC-6 human macrophage-like cell and A-549 human type II alveolar epithelial cell lines].
    Sato K; Ogasawara K; Akaki T; Tomioka H
    Kekkaku; 1999 Jul; 74(7):571-7. PubMed ID: 10481412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activities of the benzoxazinorifamycin KRM 1648 and ethambutol against Mycobacterium avium complex in vitro and in macrophages.
    Inderlied CB; Barbara-Burnham L; Wu M; Young LS; Bermudez LE
    Antimicrob Agents Chemother; 1994 Aug; 38(8):1838-43. PubMed ID: 7986017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of tumor necrosis factor, interferon-gamma, transforming growth factor-beta, and nitric oxide in the expression of immunosuppressive functions of splenic macrophages induced by Mycobacterium avium complex infection.
    Tomioka H; Sato K; Maw WW; Saito H
    J Leukoc Biol; 1995 Dec; 58(6):704-12. PubMed ID: 7499969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.